Mentoring in pediatric oncology: a report from the Children’s Oncology Group Young Investigator Committee
Levy AS1, Pyke-Grimm KA, Lee DA, Palla SL, Naranjo A, Saulnier Sholler G, Gratias E, Maloney K, Parshankar F, Lee-Scott M, Beierle EA, Gow K, Kim GE, Hunger S, Smith[...]
Phase I study of vinblastine and sirolimus in pediatric patients with recurrent or refractory solid tumors
Morgenstern DA, Marzouki M, Bartels U, Irwin MS, Sholler GL, Gammon J, Yankanah R, Wu B, Samson Y, Baruchel S. Phase I study of vinblastine and sirolimus in pediatric patients with[...]
Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel therapeutic agent for neuroblastoma
Eslin D, Sankpal U, Lee C, Sutphin R, Maliakal P, Currier E, Saulnier Sholler G, Khan M, and Basha R.. Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel[...]
A Feasibility Trial using Molecular-Guided Therapy for the Treatment of Patients with Refractory or Recurrent Neuroblastoma
Saulnier Sholler G, Bergendahl G, Vander Werff A, Dutta A, Ferguson W, Roberts W, Eslin D, Kraveka J, Kaplan J, Mitchell D, Parikh N, Neville K, Ashikaga T, Bond J,[...]
A Phase 1 Trial of DFMO as a Single Agent and in Combination with Etoposide in Patients with Refractory or Recurrent Neuroblastoma
Saulnier Sholler G, Gerner E, Bergendahl G, LaFleur B, VanderWerff A, Ashilkaga T, Ferguson W, Roberts W, Wada R, Eslin D, KravekaJ, Kaplan J, Mitchell D, Parikh N, Neville K, Sender[...]
Nifurtimox and radiation for treating neuroblastoma: a pre-clinical study
Eslin D, Lee C, Saulnier Sholler G, Sankpal U, Sutphin R, and Basha R. Nifurtimox and radiation for treating neuroblastoma: a pre-clinical study. American Association for Cancer Research Annual Meeting April 2013.[...]
Targeting both ornithine decarboxylase and polyamine transport inhibits tumor growth in neuroblastoma
Kendzicky A, Zhao P, Samal K, Yco L, McClung H, Gerner E, Bachmann A, Saulnier Sholler G. Targeting both ornithine decarboxylase and polyamine transport inhibits tumor growth in neuroblastoma. American Association for[...]
YM155 Inhibits Survivin-mediated survival, migration, and tumor growth in neuroblastoma
McClung HM, Zhao P, Eckardt A, Smith L, Saulnier Sholler G. YM155 Inhibits Survivin-mediated survival, migration, and tumor growth in neuroblastoma. American Association for Cancer Research Annual Meeting April 2013. Washington, DC.
AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport
Samal K, Zhao P, McClung H, Gerner EW, Bachmann AS, Saulnier Sholler G. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine[...]
YM155 Inhibits survivin-mediated survival, migration, and tumor growth in neuroblastoma
McClung HM, Zhao P, Smith L, Saulnier Sholler G. YM155 Inhibits survivin-mediated survival, migration, and tumor growth in neuroblastoma. Advances in Neuroblastoma Research (ANR) annual meeting June 2012, Toronto, ON.